Entering text into the input field will update the search result below

Oncternal Therapeutics grants clinical science head options for 70K shares

Jun. 02, 2022 6:04 AM ETOncternal Therapeutics, Inc. (ONCT)By: Ravikash, SA News Editor

Trading Charts on a Display

da-kuk/E+ via Getty Images

  • Oncternal Therapeutics (NASDAQ:ONCT) granted options to buy 70K common shares to its new employee Ted Shih, who joined as head, Clinical Science.
  • The award was made on June 1 under Oncternal's 2021 Employment Inducement Incentive Award Plan, and can be exercised at $1.56 per share, which was the closing price of the company's common stock on the date of the grant (June 1).

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.